Will The Magnificent 7 Stocks Go Up This Year?
2025 was another banner year for the Magnificent Seven stocks,…
Sell
29
MRMD Quote, Financials, Valuation and Earnings
Last price:
$0.09
Seasonality move
:
41.87%
Day range:
$0.09 - $0.10
52-week range:
$0.07 - $0.23
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.23x
P/B ratio:
0.65x
Volume:
299.4K
Avg. volume:
1.6M
1-year change:
-21.74%
Market cap:
$36.7M
Revenue:
$158M
EPS (TTM):
-$0.05
Analysts' Opinion
-
Consensus RatingMariMed, Inc. has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 1 Buy rating, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $0.17, MariMed, Inc. has an estimated upside of 77.42% from its current price of $0.09.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $0.08 representing 100% downside risk from its current price of $0.09.
Fair Value
-
According to the consensus of 2 analysts, MariMed, Inc. has 77.42% upside to fair value with a price target of $0.17 per share.
MRMD vs. S&P 500
-
Over the past 5 trading days, MariMed, Inc. has underperformed the S&P 500 by -1.92% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
MariMed, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
MariMed, Inc. has grown year-over-year revenues for 1 quarter straight. In the most recent quarter MariMed, Inc. reported revenues of $40.8M.
Earnings Growth
-
MariMed, Inc. earnings have been falling on a year-over-year basis for 1 quarter in a row. In the most recent quarter MariMed, Inc. reported earnings per share of -$0.01.
Enterprise value:
129.4M
EV / Invested capital:
--
Price / LTM sales:
0.23x
EV / EBIT:
104.64x
EV / Revenue:
0.82x
PEG ratio (5yr expected):
-0.09x
EV / Free cash flow:
98.73x
Price / Operating cash flow:
27.42x
Enterprise value / EBITDA:
10.03x
Gross Profit (TTM):
$32.1M
Return On Assets:
-8.59%
Net Income Margin (TTM):
-11.33%
Return On Equity:
-29.75%
Return On Invested Capital:
-10.86%
Operating Margin:
4.28%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $145.5M | $157.9M | $157.3M | $40.6M | $40.8M | |
| Gross Profit | $44M | $40.4M | $32.1M | $9.5M | $9.3M | |
| Operating Income | $15.8M | $7.6M | $1.2M | $1.7M | $1.7M | |
| EBITDA | $23.2M | $18M | $12.9M | $4.4M | $4.5M | |
| Diluted EPS | -$0.00 | -$0.04 | -$0.05 | -$0.00 | -$0.01 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $49.8M | $40.9M | $50.8M | $56.7M | $60.1M | |
| Total Assets | $118.2M | $144.7M | $190.8M | $212.7M | $205.6M | |
| Current Liabilities | $22.5M | $27.3M | $35.3M | $44.6M | $56.6M | |
| Total Liabilities | $45.2M | $55.1M | $111M | $144.8M | $151.3M | |
| Total Equity | $73M | $89.6M | $79.9M | $67.8M | $54.3M | |
| Total Debt | $25.2M | $30.8M | $81.1M | $106.5M | $99.1M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $6.4M | $10.4M | $3.9M | $803K | $2.7M | |
| Cash From Investing | -$22.2M | -$22.3M | -$2.4M | -$2.1M | -$514K | |
| Cash From Financing | $17.9M | $8.4M | -$4.7M | $917K | -$1.7M | |
| Free Cash Flow | -$11.4M | -$6.5M | $1.3M | -$1.8M | $2.1M | |
MRMD
Sector
Market Cap
$36.7M
$28.3M
Price % of 52-Week High
40.44%
51.99%
Dividend Yield
0%
0%
Shareholder Yield
1.84%
-1.59%
1-Year Price Total Return
-20.1%
-17.41%
Beta (5-Year)
1.038
0.495
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
0.35%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$0.09
200-day SMA
Sell
Level
$0.11
Bollinger Bands (100)
Sell
Level
0.09 - 0.15
Chaikin Money Flow
Buy
Level
3.1M
20-day SMA
Sell
Level
$0.10
Relative Strength Index (RSI14)
Sell
Level
46.42
ADX Line
Buy
Level
16.69
Williams %R
Buy
Level
-83.6478
50-day SMA
Sell
Level
$0.10
MACD (12, 26)
Sell
Level
0.00
25-day Aroon Oscillator
Buy
Level
32
On Balance Volume
Sell
Level
-10.9M
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (0.2779)
Sell
CA Score
(Annual)
Level (-0.845)
Buy
Beneish M-Score
(Annual)
Level (-2.6214)
Sell
Momentum Score
Level (2)
Sell
Ohlson Score
Level (2.8335)
Buy
Piotroski F Score
(Annual)
Level (4)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
MariMed, Inc. engages in the cultivation, processing, and sale of branded cannabis products. Its brands include Betty’s Eddies, Nature’s Heritage, Bubby’s Baked, Vibations, K Fusion, and InHouse. The company was founded by Robert N. Fireman and Jon R. Levine on January 25, 2011 and is headquartered in Norwood, MA.
Stock Forecast FAQ
In the current month, MRMD has received 1 Buy ratings 1 Hold ratings, and 0 Sell ratings. The MRMD average analyst price target in the past 3 months is $0.17.
-
Where Will MariMed, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that MariMed, Inc. share price will rise to $0.17 per share over the next 12 months.
-
What Do Analysts Say About MariMed, Inc.?
Analysts are divided on their view about MariMed, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that MariMed, Inc. is a Sell and believe this share price will drop from its current level to $0.08.
-
What Is MariMed, Inc.'s Price Target?
The price target for MariMed, Inc. over the next 1-year time period is forecast to be $0.17 according to 2 Wall Street analysts, 1 of them rates the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is MRMD A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for MariMed, Inc. is a Leans Bullish. 1 of 2 analysts rates the stock a Leans Bullish at this time.
-
How Can I Buy Shares Of MRMD?
You can purchase shares of MariMed, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase MariMed, Inc. shares.
-
What Is The MariMed, Inc. Share Price Today?
MariMed, Inc. was last trading at $0.09 per share. This represents the most recent stock quote for MariMed, Inc.. Yesterday, MariMed, Inc. closed at $0.09 per share.
-
How To Buy MariMed, Inc. Stock Online?
In order to purchase MariMed, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get MRMD Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
MRMD
Sector
P/E ratio
--
24.24x
PEG ratio
-0.09x
-0.01x
P/B ratio
0.65x
1.84x
Price / LTM sales
0.23x
1.60x
Growth Metrics
MRMD
Sector
Revenue growth
0.43%
4.6%
Earnings growth
-177.78%
10.71%
Revenue (5-year growth)
28.21%
6.45%
Earnings forecast
-$0.01
-$0.19
Profitability
MRMD
Sector
Profitability FY 2024
$35.8M
$3.5M
Return on invested capital
-10.86%
-32.04%
Return on assets
-8.59%
-28.44%
Return on equity
-29.75%
-38.09%
Earnings Date
Last Earnings Date
Nov
5
Next Earnings Date
Mar
4
Estimated Next Earnings Date
Feb
4
Balance Sheet
MRMD
Sector
Total cash
$6.6M
$26.1M
Short term investments
--
$25.7M
Total assets
$207M
$76.4M
Long term debt
$99.1M
$3.2M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Did Planet Labs Stock Rally So Much?
Satellite imaging startup Planet Labs (NYSE:PL), after years of disappointing…
Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Stock Ideas
Buy
52
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
65
Is GOOG Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 41x
Buy
51
Is GOOGL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 40x
Alerts
Buy
100
ATGL alert for Jan 10
Alpha Technology Group Ltd. [ATGL] is up 47.05% over the past day.
Buy
65
RGC alert for Jan 10
Regencell Bioscience Holdings Ltd. [RGC] is up 10.55% over the past day.
Sell
50
NAIL alert for Jan 10
Direxion Daily Homebuilders & Supplies Bull 3X Shs [NAIL] is up 18.52% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
